Better Buy: Biogen Inc. vs. Gilead Sciences
Historically, Biogen (NASDAQ: BIIB) has definitely been a better stock than Gilead Sciences (NASDAQ: GILD). Whether you look at the last three, five, 10, 25 years, or even so far in 2017, Biogen has outperformed Gilead.
But for investors, the future matters a whole lot more than the past. Which of these two big biotech stocks is the better pick going forward? Here's how Biogen and Gilead Sciences compare.
Image source: Getty Images.
Source: Fool.com
Gilead Sciences Inc Stock
€122.84
-2.850%
The stock is an absolute favorite of our community with 65 Buy predictions and no Sell predictions.
With a target price of 128 € there is a slightly positive potential of 4.2% for Gilead Sciences Inc compared to the current price of 122.84 €.
